Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms


CHROMONE derivatives exhibiting unusual biological activity have been studied in these laboratories for several years. One of these, disodium cromoglycate (FPL 670), has been found to inhibit specifically the liberation of the mediators of anaphylaxis initiated by the interaction of antigen with reagin type antibodies. It is neither a bronchodilator nor an anti-inflammatory agent and its action is distinct from that of corticosteroids.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Altounyan, R. E. C., Acta Allergologica (in the press).

  2. Howell, J. B. L., and Altounyan, R. E. C., Lancet, ii, 539 (1967).

  3. Mota, I., Life Sci., 1, 465; ibid., 917 (1963).

    Article  Google Scholar 

  4. Ogilvie, B. M., Nature, 204, 91 (1964).

    ADS  CAS  Article  Google Scholar 

  5. Sheard, P., Killingback, P. G., and Blair, A. M. J. N., Nature, 216, 283 (1967).

    ADS  CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

COX, J. Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms. Nature 216, 1328–1329 (1967).

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing